Study guide
8.2 Advanced Resuscitation: Chest Compressions & Emergency Medications
NCC Low Risk Neonatal Nursing RNC-LRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Maternal-Fetal Risk Assessment
1.1 RNC-LRN Exam Structure, Eligibility & Test Blueprint 1.2 Maternal Health Conditions & Prenatal Risk Factors 1.3 Intrapartum Events & Fetal Surveillance Interpretation 1.4 Antepartum Fetal Surveillance, Labor Progression & Perinatal Screening
2 Chapter 2: Comprehensive Neonatal Assessment & Gestational Age
2.1 Physical Assessment & Normal Variations vs. Abnormalities 2.2 Gestational Age Assessment: New Ballard Score & Maturity Classification 2.3 Neurobehavioral Assessment & Primitive Reflexes
3 Chapter 3: Neonatal Diagnostic & Laboratory Evaluation
3.1 Neonatal Blood Gas Interpretation & Acid-Base Balance 3.2 Hematologic & Metabolic Laboratory Diagnostics 3.3 Newborn Screening & Diagnostic Imaging Modalities
4 Chapter 4: Neonatal Respiratory Pathophysiology & Management
4.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 4.2 Transient Tachypnea of the Newborn (TTN) 4.3 Meconium Aspiration Syndrome (MAS) & Air Leaks 4.4 Apnea of Prematurity (AOP) & Persistent Pulmonary Hypertension (PPHN) 4.5 Oxygenation Assessment & Non-Invasive Respiratory Support
5 Chapter 5: Neonatal Cardiovascular Conditions & Hemodynamics
5.1 Fetal-to-Neonatal Circulatory Transition & Innocent Murmurs 5.2 Patent Ductus Arteriosus (PDA) & Ductal-Dependent Cardiac Lesions 5.3 Congenital Heart Defects & CCHD Pulse Oximetry Screening
6 Chapter 6: Neurologic & Gastrointestinal/Genitourinary Disorders
6.1 Hypoxic-Ischemic Encephalopathy (HIE) & Therapeutic Hypothermia 6.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 6.3 Gastrointestinal Pathologies & Necrotizing Enterocolitis (NEC) 6.4 Congenital GI/GU Anomalies & Renal Function
7 Chapter 7: Hematology, Hyperbilirubinemia, and Genetic/Endocrine Conditions
7.1 Neonatal Hyperbilirubinemia & Kernicterus Risk 7.2 Hemolytic Disease & Neonatal Hematologic Disorders 7.3 Inborn Errors of Metabolism & Endocrine Disorders 7.4 Infant of a Diabetic Mother (IDM) & Chromosomal Anomalies
8 Chapter 8: Resuscitation & Immediate Neonatal Stabilization
8.1 Neonatal Resuscitation Program (NRP) 9th Edition Core Algorithm 8.2 Advanced Resuscitation: Chest Compressions & Emergency Medications 8.3 Post-Resuscitation Stabilization & The S.T.A.B.L.E. Framework
9 Chapter 9: Nutrition, Feeding & Gastrointestinal Support
9.1 Maternal Breast Milk, Lactation Support & Donor Milk 9.2 Nutritional Fortification & Specialized Formula Selection 9.3 Enteral Feeding Methods, Trophic Feeds & Gavage Administration
10 Chapter 10: Thermoregulation, Fluids, Electrolytes & Glucose Management
10.1 Thermoregulation & Prevention of Cold Stress 10.2 Fluid Requirements & Electrolyte Management 10.3 Neonatal Hypoglycemia Assessment & Management Protocols
11 Chapter 11: Infection Control, Sepsis & Neonatal Pharmacology
11.1 Early-Onset vs. Late-Onset Sepsis & Maternal GBS Management 11.2 Infection Prevention, CLABSI Bundles & Antimicrobial Stewardship 11.3 Neonatal Pharmacology & High-Alert Medication Administration 11.4 Congenital & Perinatal Infections, Sexually Transmitted Infections and Immune Function 11.5 Vitamin K, Eye Prophylaxis, Immunization & Routine Neonatal Medications
12 Chapter 12: Neurodevelopmental Care, Family-Centered Care & Discharge Transition
12.1 Developmental Care, Stress Reduction & Non-Pharmacologic Pain Management 12.2 Neonatal Abstinence Syndrome (NAS/NOWS) & Eat, Sleep, Console (ESC) 12.3 Discharge Readiness, Car Seat Challenge & Safe Sleep Education 12.4 Psychosocial Support, Family Adaptation & Perinatal Grief 12.5 Home Care Technology, Developmental Follow-Up & Community Referral
13 Chapter 13: Professional Issues, Safety, Quality & Ethics in Neonatal Nursing
13.1 Patient Safety, Error Prevention & Quality Improvement 13.2 Bioethics, Legal Standards & Family Advocacy
14 Chapter 14: Musculoskeletal, Integumentary & Birth Injury Conditions
14.1 Musculoskeletal Anomalies & Neonatal Birth Injuries 14.2 Neonatal Skin: Barrier Physiology, Normal Variations & Common Lesions
8.2 Advanced Resuscitation: Chest Compressions & Emergency Medications
Key Takeaways Explain This Topic AI
A rising heart rate is the single most important indicator of successful ventilation; if the heart rate is not increasing after 15 to 30 seconds and the chest is not moving, the clinician must perform the MR. SOPA ventilation corrective steps.
The MR. SOPA mnemonic covers Mask adjustment, Reposition airway, Suction mouth/nose, Open mouth, Pressure increase (5 cmH2O increments up to 30–40 cmH2O), and Alternative airway; the 9th Edition dropped the strict sequence requirement, so the clinician may prioritize whichever corrective step the assessment suggests is most likely to help.
The 9th Edition endotracheal tube table is keyed to grams: < 800 g = 2.5 mm (optional 2.0 mm), 800–1,200 g = 2.5 mm, 1,201–2,200 g = 3.0 mm, > 2,200 g = 3.5 mm; depth is estimated as weight in kg + 6 cm or nasal-tragus length + 1 cm and is now read at the anterior edge of the upper (maxillary) gum — tip-to-gum, not tip-to-lip.
Chest compressions are indicated when heart rate remains < 60 bpm despite at least 30 seconds of effective PPV that inflates the lungs (via ETT or LMA); perform compressions using the 2-thumb encircling-hands technique on the lower 1/3 of the sternum at a 3:1 ratio (90 compressions + 30 breaths = 120 events/min) with 100% FiO2.
Intravenous/Intraosseous Epinephrine (1:10,000 / 0.1 mg/mL at 0.02 mg/kg [0.2 mL/kg] with 3 mL normal saline flush) is indicated if HR remains < 60 bpm after 60 seconds of coordinated CPR/PPV with 100% O2; Volume expanders (Normal Saline 10 mL/kg over 5–10 min) are indicated for hypovolemic shock or acute fetal blood loss.
Last updated: October 2026
8.2 Advanced Resuscitation: Chest Compressions & Emergency Medications
Clinical Pearl & Core Takeaway: In neonatal resuscitation, chest compressions and emergency medications will never be effective unless the lungs are already adequately ventilated and inflated . If the heart rate is < 60 bpm, the primary defect is almost always uncorrected hypoxemia and inadequate alveolar ventilation. Before initiating compressions, ensure that effective PPV is being delivered—evidenced by bilateral chest rise—preferably via an secured endotracheal tube or laryngeal mask airway.
1. Assessing PPV Efficacy & The MR. SOPA Corrective Steps
The infant's heart rate response is the single most sensitive indicator of successful ventilation . The 9th Edition lengthened the first assessment interval: the team now assesses heart rate 15 to 30 seconds after starting ventilation (the 8th Edition said 15 seconds), which allows a genuinely effective inflation sequence to be established before the corrective steps are triggered:
First Heart Rate Check (After 15 to 30 seconds of ventilation):
If HR is rising: Announce "Heart rate is rising." Continue PPV for another 15 to 30 seconds and reassess.
If HR is NOT rising, but the chest IS moving: Announce "Heart rate is not rising, but chest is moving." Continue PPV that moves the chest for another 15 to 30 seconds and reassess.
If HR is NOT rising, and the chest is NOT moving: Announce "Heart rate is not rising, chest is NOT moving." Immediately stop and perform the MR. SOPA Ventilation Corrective Steps .
The MR. SOPA Troubleshooting Matrix
MR. SOPA is traditionally executed in paired steps, delivering 5 positive pressure breaths after each pair and observing for chest movement. The 9th Edition removed the requirement to run the steps in strict sequence: based on your assessment of the infant and the clinical situation, you may choose the steps most likely to be helpful and prioritize the order in which you perform them. For example, if you can see that the mouth is full of secretions, go to S first rather than working mechanically through M and R .
Step Corrective Action Technical Execution & Clinical Rationale
M Mask Adjustment Reapply the mask using the "C-clamp" technique (thumb and index finger forming a C over mask rim, 3rd, 4th, 5th fingers lifting bony mandible into mask). Ensure an airtight seal around nose and mouth without pressing on eyes.
R Reposition Airway Place head/neck in neutral "sniffing" position . Adjust shoulder roll to prevent neck flexion.; --> Deliver 5 test breaths: If chest moves, continue PPV. If not, proceed to S & O.
S Suction Mouth & Nose Suction mouth first, then nose using a bulb syringe or 10–12 Fr suction catheter (80–100 mmHg) to clear thick mucus, blood, or meconium.
O Open Mouth Lift the mandible upward and gently open the infant's mouth using your thumb or fingers to relieve tongue obstruction.; --> Deliver 5 test breaths: If chest moves, continue PPV. If not, proceed to P.
P Pressure Increase Increase Peak Inspiratory Pressure (PIP) in increments of 5 cmH 2 O \text{cmH}_2\text{O} cmH 2 O (e.g., from 25 to 30, up to 35–40 cmH 2 O \text{cmH}_2\text{O} cmH 2 O for term infants) until bilateral chest rise is visible.; --> Deliver 5 test breaths: If chest moves, continue PPV. If not, proceed to A.
A Alternative Airway Insert an Endotracheal Tube (ETT) or place a Laryngeal Mask Airway (LMA) . Secure the airway and deliver positive pressure ventilation directly through the artificial airway.
Loading diagram... MR. SOPA Ventilation Troubleshooting Flowchart
2. Advanced Airway: Endotracheal Intubation & Laryngeal Mask Airway
When bag-mask ventilation is ineffective (fails MR. SOPA), prolonged PPV is required, chest compressions are indicated, or specific clinical conditions exist (e.g., Congenital Diaphragmatic Hernia), an alternative airway must be established.
Endotracheal Equipment & Sizing Chart
The 9th Edition re-keyed this table to grams rather than kilograms, added a dedicated row for infants under 800 grams, and raised the weight cut-offs (2.5 mm now extends to 1,200 g and 3.0 mm to 2,200 g):
- Estimated Weight Gestational Age ETT Internal Diameter (ID) Laryngoscope Blade Size
- < 800 grams 22 to 25 weeks 2.5 mm uncuffed (an optional 2.0 mm ID tube may be considered) Miller 00
- 800 to 1,200 grams 26 to 28 weeks 2.5 mm uncuffed Miller 00
- 1,201 to 2,200 grams 29 to 34 weeks 3.0 mm uncuffed Miller 0
- > 2,200 grams > 34 weeks 3.5 mm uncuffed Miller 1
- Intubation Procedure & Depth Estimation
Intubation Attempt Duration: Limit each intubation attempt to < 30 seconds . If unsuccessful within 30 seconds, stop, resume bag-mask PPV, re-oxygenate, and attempt again.
Depth of Insertion Estimation:
Weight-Based Formula: Estimated insertion depth (cm) = Estimated Weight in kg + 6 cm \text{Estimated Weight in kg} + 6\text{ cm} Estimated Weight in kg + 6 cm (e.g., a 1 kg infant is intubated to 7 cm; a 2 kg infant to 8 cm; a 3 kg infant to 9 cm).
Where the depth mark is read (changed in the 9th Edition): insert the tube so that the marking corresponding to the estimated depth sits at the anterior edge of the baby's upper (maxillary) gum in the midline — "tip-to-gum." The 8th Edition measured to the lip , a soft, mobile landmark that shifts with tape and mask pressure; the gum line is a fixed bony reference and yields a more reproducible depth.
Nasal-Tragus Length (NTL) Method: Measure distance from the nasal septum to the tragus of the ear (cm) and add 1 cm: Depth (cm) = NTL + 1 cm \text{Depth (cm)} = \text{NTL} + 1\text{ cm} Depth (cm) = NTL + 1 cm .
Confirmation of Endotracheal Tube Placement
Primary Confirmation ( E t CO 2 Et\text{CO}_2 Et CO 2 Detection): Attach a colorimetric end-tidal CO 2 \text{CO}_2 CO 2 detector between the ETT and resuscitator. A distinct color change from purple/blue (room air) to yellow (exhaled CO 2 \text{CO}_2 CO 2 ) during 5 to 6 consecutive positive pressure exhalations confirms tracheal placement. (Note: In infants with cardiac arrest or severely reduced pulmonary blood flow, E t CO 2 Et\text{CO}_2 Et CO 2 may remain pale purple/tan until cardiac output improves).
Secondary Clinical Confirmation: Rapidly rising heart rate; bilateral symmetric chest excursions; equal breath sounds auscultated in both axillae with absence of gastric gurgling.
Radiographic Confirmation: Post-resuscitation chest X-ray must demonstrate the ETT tip in the mid-trachea at the level of the T2 to T3 vertebral bodies , well above the carina (T4).
Laryngeal Mask Airway (LMA / Supraglottic Airway)
Primary device status (changed in the 9th Edition): the laryngeal mask is no longer a rescue-only airway. The 9th Edition states that in most cases ventilation is initiated with a face mask or a laryngeal mask — you may reach for it as a primary device rather than waiting until the face mask and intubation have both failed. This matters in Level I/II settings where a skilled intubator may not be immediately available.
Indications: Newborns born at ≥ 34 weeks gestation and weighing ≥ 1.5 to 2.0 kg ; particularly valuable when facial malformations (e.g., Pierre Robin sequence, cleft lip/palate, micrognathia) prevent a tight mask seal or when endotracheal intubation is unsuccessful ("cannot ventilate, cannot intubate").
Size: Size 1 supraglottic mask; inserted blindly over the tongue until seated over the laryngeal inlet, and inflated with up to 2 to 4 mL of air.
3. Chest Compressions in Neonatal Resuscitation
Chest compressions are indicated only when the heart rate remains < 60 bpm despite at least 30 seconds of effective positive pressure ventilation that moves the chest (preferably delivered through an endotracheal tube or laryngeal mask).
Compression Technique & Mechanics
Two-Thumb Encircling-Hands Technique (Gold Standard):
The rescuer stands at the head or side of the bed, encircling the neonate's thorax with both hands.
Both thumbs are placed on the lower third of the sternum , located immediately below the intermammary nipple line and above the xiphoid process.
The fingers support the infant's back to provide a firm counter-support surface.
The two-finger method is not used (it generates lower peak arterial pressures and tires the provider); if an umbilical line is needed, the compressor moves to the head of the bed and continues two-thumb compressions.
Depth of Compression: Depress the sternum approximately one-third of the anterior-posterior (AP) diameter of the chest .
Recoil: Allow full chest recoil between compressions; do not remove thumbs from the chest wall.
Ratio, Cadence, & Oxygen Concentration
Compression-to-Ventilation Ratio: 3:1 ratio (3 compressions to 1 positive pressure breath).
Frequency: Deliver 90 compressions and 30 breaths per minute (total of 120 events per minute). This provides 2 seconds per cycle (3 compressions over 1.5 seconds, 1 breath over 0.5 second).
Verbal Cadence: Rescuers count aloud in synchronized rhythm: "One-and-two-and-three-and-breathe; One-and-two-and-three-and-breathe..."
Oxygen Concentration ( FiO 2 \text{FiO}_2 FiO 2 ): When chest compressions are initiated, immediately increase FiO 2 \text{FiO}_2 FiO 2 to 100% on the oxygen blender. Once heart rate recovers above 60 bpm and compressions stop, titrate FiO 2 \text{FiO}_2 FiO 2 back down based on target pre-ductal S p O 2 SpO_2 Sp O 2 .
Evaluation & Timing
Continue coordinated CPR (compressions and PPV with 100% FiO 2 \text{FiO}_2 FiO 2 ) for 60 continuous seconds before pausing briefly to evaluate the heart rate.
Assess heart rate using 3-lead ECG (preferred) or auscultation. Stop compressions once the heart rate is ≥ 60 bpm .
4. Emergency Medications & Volume Expansion
If the infant's heart rate remains < 60 bpm despite at least 60 seconds of coordinated chest compressions and effective PPV with 100% FiO 2 \text{FiO}_2 FiO 2 , emergency medications and volume expansion are indicated.
Epinephrine (Adrenaline)
Epinephrine stimulates α \alpha α -adrenergic receptors, causing peripheral vasoconstriction that increases aortic diastolic pressure and drives coronary and cerebral perfusion during CPR. +-------------------------------------------------------------------------------------------------------+
- | EPINEPHRINE DOSING PROTOCOL (NRP 9th Ed.) |
- | |
- | Concentration: 1:10,000 (0.1 mg/mL) |
- | |
- | [PREFERRED] IV or IO Route: |
- | * Dose: 0.02 mg/kg (= 0.2 mL/kg of 1:10,000 solution) |
- | * Dosing Range: 0.01 to 0.03 mg/kg (0.1 to 0.3 mL/kg) |
- | * Follow immediately with a 3 mL Normal Saline flush to clear line |
- | |
- | [TEMPORARY ONLY] Endotracheal (ET) Route: |
- | * Dose: 0.1 mg/kg (= 1.0 mL/kg of 1:10,000 solution) |
- | * Dosing Range: 0.05 to 0.1 mg/kg (0.5 to 1.0 mL/kg) |
- | * Do NOT flush with saline; deliver several positive pressure breaths to distribute into lungs |
- | |
- | Repeat Dosing: Every 3 to 5 minutes if HR remains < 60 bpm (Titrate IV doses up to 0.03 mg/kg) |
- +-------------------------------------------------------------------------------------------------------+
- Volume Expansion
Indications: Suspected acute blood loss or hypovolemic shock (e.g., maternal placental abruption, vasa previa, cord rupture, feto-maternal hemorrhage) accompanied by persistent bradycardia, pale/mottled skin, prolonged capillary refill (> 3 seconds), or weak/absent pulses unresponsive to ventilation and compressions.
Fluid of Choice:
0.9% Sodium Chloride (Normal Saline) — crystalloid of choice.
Emergency uncrossed Type O, Rh-negative Packed Red Blood Cells (PRBCs) — indicated for documented severe acute fetal hemorrhage.
Dose & Administration: 10 mL/kg IV or IO , administered as a steady infusion over 5 to 10 minutes . (Caution: In extreme preterm infants, rapid boluses < 5 minutes can cause sudden cerebral blood flow surges and intraventricular hemorrhage).
Emergency Vascular Access
Emergency Umbilical Venous Catheter (UVC):
The umbilical vein is a single, large, thin-walled vessel located at the 12 o'clock position in the cord stump (compared to the two smaller, thick-walled muscular umbilical arteries at 4 and 8 o'clock).
Catheter Size: 3.5 Fr (< 3.5 kg) or 5.0 Fr (≥ 3.5 kg).
Insertion Depth: Insert catheter 2 to 4 cm (or until free blood return is obtained upon aspiration with a syringe). This is a "low emergency placement" positioned below the liver in the inferior vena cava or ductus venosus to avoid hepatic necrosis from hypertonic infusions.
Intraosseous (IO) Needle Access:
Placed when umbilical venous catheterization is difficult or impossible.
Anatomical Site: Proximal tibia, on the flat anteromedial surface 1 to 2 cm below and medial to the tibial tuberosity .
Delivers fluids and emergency medications directly into the medullary venous plexus.
Resuscitation Cessation Guidelines
According to NRP 9th Edition guidelines, if the infant's heart rate remains completely absent (0 bpm) after 20 minutes of continuous, high-quality resuscitation (confirming that all steps of ventilation, intubation, compressions, epinephrine, and volume have been properly executed), cessation of resuscitation efforts is ethically and clinically appropriate in consultation with the team and family.